PRIA Logo™
119-s-3729119th Congress

PBM Reporting Transparency Act

Sponsored By: Senator Warner, Mark R. [D-VA]

Introduced

Summary

Greater transparency on pharmacy benefit manager (PBM) contracts with Medicare drug plans. This bill would require the Medicare Payment Advisory Commission to analyze PBM agreements for Medicare prescription drug plans and Medicare Advantage prescription drug plans and report trends, impacts on costs, and recommendations.

Show full summary
  • Medicare enrollees would get clearer analysis of how PBM agreements affect out-of-pocket prescription spending.
  • Pharmacies would see aggregated reporting on average pharmacy reimbursement that highlights payment patterns across plans.
  • Prescription drug plans and Medicare Advantage prescription drug plans would have their PBM contracts described and compared to show differences in deal terms and effects.
  • Policymakers would receive an initial report after the Secretary makes data available and a final report two years after the initial submission, each including trends, comparisons, and any recommendations.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Warner, Mark R. [D-VA]

VA • D

Cosponsors

  • Sen. Tillis, Thomas [R-NC]

    NC • R

    Sponsored 1/29/2026

  • Sen. Cortez Masto, Catherine [D-NV]

    NV • D

    Sponsored 1/29/2026

  • Sen. Marshall, Roger [R-KS]

    KS • R

    Sponsored 1/29/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation